Login | Users Online: 54  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
 
This article has been cited by
1Queueing theory model of pentose phosphate pathway
Sylwester M. Kloska,Krzysztof Palczynski,Tomasz Marciniak,Tomasz Talaska,Marissa Miller,Beata J. Wysocki,Paul Davis,Tadeusz A. Wysocki
Scientific Reports.2022;12(1)
[DOI]
2Queueing theory model of pentose phosphate pathway
Douglas J. Anderson,Benjamin M. Martin,Allan D. Kirk,David H. Sachs
Scientific Reports.2014;12(1)185
[DOI]
3Queueing theory model of pentose phosphate pathway
Eric Schneider,Veljko Dubljevic
Scientific Reports.2022;12(1)223
[DOI]
4Biologia futura: animal testing in drug development—the past, the present and the future
Miklós Sántha
Biologia Futura.2020;71(4)443
[DOI]
5Assessment of Cryosurgical Device Performance Using a 3D Tissue-Engineered Cancer Model
John M. Baust,Anthony Robilotto,Kristi K. Snyder,Kimberly Santucci,Jennie Stewart,Robert Van Buskirk,John G. Baust
Technology in Cancer Research & Treatment.2017;16(6)900
[DOI]
6Remote vitals monitoring in rodents using video recordings
Janosch Kunczik,Carina Barbosa Pereira,Leonie Zieglowski,René Tolba,Laura Wassermann,Christine Häger,André Bleich,Heike Janssen,Thomas Thum,Michael Czaplik
Biomedical Optics Express.2019;10(9)4422
[DOI]
7The Coming of Age of Biosimilars: A Personal Perspective
Sarfaraz K. Niazi
Biologics.2022;2(2)107
[DOI]
8The Coming of Age of Biosimilars: A Personal Perspective
Meagan K. Mann
Biologics.2017;1266(2)45
[DOI]
9The Coming of Age of Biosimilars: A Personal Perspective
Colin G. Scanes,Pu Chengzhong
Biologics.2018;1266(2)257
[DOI]
10The Coming of Age of Biosimilars: A Personal Perspective
Bryan N. Brown,Martin J. Haschak,Alexis L. Nolfi,Mangesh Kulkarni
Biologics.2020;1266(2)1509
[DOI]
11Manoeuvrability and biocompatibility of endodontic tricalcium silicate-based putties
Qin Sun,Meng Meng,Jeffrey N. Steed,Stephanie J. Sidow,Brian E. Bergeron,Li-na Niu,Jing-zhi Ma,Franklin R. Tay
Journal of Dentistry.2021;104(2)103530
[DOI]
12Manoeuvrability and biocompatibility of endodontic tricalcium silicate-based putties
Bonnie Beaver,Gail Golab
Journal of Dentistry.2023;104(2)67
[DOI]
13Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue
Mandy B. Esch,Hidetaka Ueno,Dawn R. Applegate,Michael L. Shuler
Lab on a Chip.2016;16(14)2719
[DOI]
14A simple method to study motor and non-motor behaviors in adult zebrafish
Velanganni Selvaraj,Hemagowri Venkatasubramanian,K. Ilango,Kirankumar Santhakumar
Journal of Neuroscience Methods.2019;320(14)16
[DOI]
15Biosimilars: A futuristic fast-to-market advice to developers
Sarfaraz K. Niazi
Expert Opinion on Biological Therapy.2022;22(2)149
[DOI]
16Biosimilars: A futuristic fast-to-market advice to developers
Klaus Rose
Expert Opinion on Biological Therapy.2021;22(2)337
[DOI]
17Biosimilars: A futuristic fast-to-market advice to developers
Lee Ann Hodges
Expert Opinion on Biological Therapy.2017;22(2)359
[DOI]
18Assessment of Cardiotoxicity With Stem Cell-based Strategies
Aaltje Maria Stella Stoter,Marc N. Hirt,Justus Stenzig,Florian Weinberger
Clinical Therapeutics.2020;42(10)1892
[DOI]
19A review of 28 free animal-tracking software applications: current features and limitations
Veronica Panadeiro,Alvaro Rodriguez,Jason Henry,Donald Wlodkowic,Magnus Andersson
Lab Animal.2021;50(9)246
[DOI]
20Prenatal smoking and genetic risk: Examining the childhood origins of externalizing behavioral problems
Melissa A. Petkovsek,Brian B. Boutwell,Kevin M. Beaver,J.C. Barnes
Social Science & Medicine.2014;111(9)17
[DOI]
21Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations
Gabrielle Gimenes Lima,Amanda Izeli Portilho,Elizabeth De Gaspari
Pathogens.2022;12(1)20
[DOI]
22The Scientist Citizen and the Citizen Scientist: Blurring the Lines
Lane Warmbrod,Marc Trotochaud,Nancy Connell
ILAR Journal.2019;60(1)5
[DOI]
23Three-Dimensional Bioprinting of an In Vitro Lung Model
Nádia Nascimento da Rosa,Julia Maurer Appel,Ana Carolina Irioda,Bassam Felipe Mogharbel,Nathalia Barth de Oliveira,Maiara Carolina Perussolo,Priscila Elias Ferreira Stricker,Lívia Rosa-Fernandes,Cláudio Romero Farias Marinho,Katherine Athayde Teixeira de Carvalho
International Journal of Molecular Sciences.2023;24(6)5852
[DOI]
24Three-Dimensional Bioprinting of an In Vitro Lung Model
Yoshito Tsuruda,Shingo Akita,Kotomi Yamanaka,Masataka Yamamoto,Yoshitake Sano,Teiichi Furuichi,Hiroshi Takemura
International Journal of Molecular Sciences.2023;24(6)1
[DOI]
25Causal Criteria in Medical and Biological Disciplines: History, Essence, and Radiation Aspect. Report 3, Part 2: Hill’s Last Four Criteria: Use and Limitations
A. N. Koterov
Biology Bulletin.2022;49(11)2184
[DOI]
26Causal Criteria in Medical and Biological Disciplines: History, Essence, and Radiation Aspect. Report 3, Part 2: Hill’s Last Four Criteria: Use and Limitations
Pradip Chaudhari
Biology Bulletin.2015;49(11)203
[DOI]
27The Ontology of Oncology: Navigating Cyborgs and Assemblages Through Cancer Treatment
Jay Baglia
Health Communication.2022;49(11)1
[DOI]
28Animal Models to Investigate the Pathogenesis of Rheumatic Heart Disease
Catherine M. Rush,Brenda L. Govan,Suchandan Sikder,Natasha L. Williams,Natkunam Ketheesan
Frontiers in Pediatrics.2014;2(11)1
[DOI]
29Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
Sarfaraz K. Niazi,Waleed Mohammed Al-Shaqha,Zafar Mirza
Journal of Market Access & Health Policy.2023;11(1)1
[DOI]
30A Review of Freely Available, Open-Source Software for the Automated Analysis of the Behavior of Adult Zebrafish
Juan E. Franco-Restrepo,Diego A. Forero,Rafael A. Vargas
Zebrafish.2019;16(3)1
[DOI]
31Bioprinting Organotypic Hydrogels with Improved Mesenchymal Stem Cell Remodeling and Mineralization Properties for Bone Tissue Engineering
Daniela Filipa Duarte Campos,Andreas Blaeser,Kate Buellesbach,Kshama Shree Sen,Weiwei Xun,Walter Tillmann,Horst Fischer
Advanced Healthcare Materials.2016;5(11)1336
[DOI]
32Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
Mikkel Bo Brent
Pharmacology & Therapeutics.2023;244(11)108383
[DOI]
33Embracing Medication Needs of Patients based on Ethical, Dietary, and Religious Preferences
Lena Tieu,Jasmine Uchi,Nirva Patel,Mihir Meghani,Padmaja Patel,Yen Nguyen
American Journal of Lifestyle Medicine.2022;244(11)155982762211355
[DOI]
34Embracing Medication Needs of Patients based on Ethical, Dietary, and Religious Preferences
Chao Min,Eunmi Lee,Li Zhao
American Journal of Lifestyle Medicine.2018;244(11)93
[DOI]
35Embracing Medication Needs of Patients based on Ethical, Dietary, and Religious Preferences
R.K. Athira,R. Kripamol,M.S. Anju,B. Maya,Roopesh R. Pai,Shilpa Ajit,M.R. Aswathy,Anil Kumar P.R.,Naresh Kasoju
American Journal of Lifestyle Medicine.2022;244(11)501
[DOI]
36Embracing Medication Needs of Patients based on Ethical, Dietary, and Religious Preferences
Johanna Sapi
American Journal of Lifestyle Medicine.2017;244(11)000157
[DOI]
37Replacement Strategies for Animal Studies in Inhalation Testing
Eleonore Fröhlich
Sci.2021;3(4)45
[DOI]
38Queueing theory model of Krebs cycle
Sylwester Kloska,Krzysztof Palczynski,Tomasz Marciniak,Tomasz Talaska,Marissa Nitz,Beata J Wysocki,Paul Davis,Tadeusz A Wysocki,Pier Luigi Martelli
Bioinformatics.2021;37(18)2912
[DOI]
39Willingness to participate in HIV research at the end of life (EOL)
Katya Prakash,Sara Gianella,Karine Dubé,Jeff Taylor,GaYoung Lee,Davey M. Smith,Leonid Margolis
PLOS ONE.2018;13(7)e0199670
[DOI]
40Willingness to participate in HIV research at the end of life (EOL)
Wafaa El Sayed Abd El-Aal
PLOS ONE.2014;13(7)17
[DOI]
  Feedback 
  Subscribe